Safety and Efficacy of Adaptive Deep Brain Stimulation

Summary

The aim of this study is to assess the safety and the potential efficacy of personalized Local Field Potential (LFP)-based adaptive Deep Brain Stimulation (aDBS), using the implantable pulse generator (IPG) of the "AlphaDBS" System, in Parkinson's Disease patients, chronically implanted in subthalamic nucleus (STN) for DBS.

Eligibility

IPG Replacement Patients: Inclusion Criteria 1. Diagnosis of idiopathic PD; 2. Subject is bilaterally treated with DBS in the STN using a Medtronic Activa PC or Activa RC IPG (mono-channnel or dual channel); 3. DBS implant for at least 3 years and in need of battery replacement within 12 months af

Locations